SLC26A4
protein-codingsolute carrier family 26 member 4, the group of Solute carrier family 26
Gene summary
Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene; they have similar genomic structures and this gene is located 3' of the SLC26A3 gene. The encoded protein has homology to sulfate transporters. [provided by RefSeq, Jul 2008]
- DFNB4
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~57.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0019588
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0010134
Submitter: Natera
Inheritance Pattern: AD
Disease ID:MONDO:0019861
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0010933
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0010134
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0010933
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0010134
Submitter: ClinGen
The association between SLC26A4 and autosomal recessive Pendred syndrome is well-established and over 500 variants have been reported, including missense, nonsense, frameshift, splice, in-frame indel, and large deletion variants. The hearing loss associated with SLC26A4 is typically congenital, pre-, or peri-lingual in onset and caused by enlarged vestibular aqueduct (EVA). An incomplete partitioning defect of the cochlea may also be present. Goiter and/or hypothyroidism are an incompletely penetrant feature of Pendred syndrome and may not present until the second decade of life (Pryor 2005, Soh 2015). There may be variable expression of the thyroid features, even within families with the same pathogenic variants. Additionally, a large percentage of individuals with hearing loss and EVA lack variants on one or both alleles of SLC26A4. Individuals with a single mutation appear to be less likely to develop the thyroid features, but may have similar recurrence risks as individuals found to harbor two biallelic pathogenic variants (Pryor 2005, Chattaraj 2014). This gene-disease association is supported by animal models, evidence of expression in the ear and thyroid, and in vitro biochemical studies. In summary, SLC26A4 is definitively associated with autosomal recessive Pendred syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Hearing Loss Working Group on 6/7/2017.
Inheritance Pattern: AR
Disease ID:MONDO:0010134
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0019855
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0010933
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0010134
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Endocrine
Intervention: Audiologic/Otolaryngologic; Endocrine
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; In Pendred syndrome, surveillance for and treatment of thyroid abnormalities can be beneficial
Comments: Promoter variants have been reported as causative; Digenic inheritance (with KCNJ10) has been reported
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SLC26A4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000441.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 14 | 348 | 1 | 368 | |
| missense | 58 | 229 | 310 | 26 | 5 | 628 |
| nonsense | 51 | 39 | 1 | 91 | ||
| start loss | 2 | 3 | 5 | |||
| frameshift | 89 | 84 | 2 | 175 | ||
| splice donor/acceptor (+/-2bp) | 33 | 71 | 2 | 106 | ||
| Total | 233 | 431 | 329 | 374 | 6 | 1373 |
Highest pathogenic variant AF is 0.001305661
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000432.1 | 20 | MANE Select | |
| Ensembl | ENSP00000494017.1 | 20 | MANE Select | |
| Ensembl | ENSP00000394760.1 | 3 | Standard | |
| Ensembl | ENSP00000494344.1 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Thyroid hormone synthesis - Homo sapiens (human)
- Tyrosine metabolism
- Biopterin metabolism
- Transport of inorganic cations/anions and amino acids/oligopeptides
- SLC-mediated transmembrane transport
Biological Process
- ion transport
- regulation of pH
- sensory perception of sound
- sulfate transport
- inorganic anion transport
Molecular Function
- secondary active sulfate transmembrane transporter activity
- bicarbonate transmembrane transporter activity
- chloride transmembrane transporter activity
- iodide transmembrane transporter activity
- sulfate transmembrane transporter activity
Cellular Component
- plasma membrane
- integral component of plasma membrane
- apical plasma membrane
- brush border membrane
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000265715
- Coding exons
- 20
- Length
- 57175
- Individuals with no LoFs
- 125497
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 251
- Defined
- 125748
- p
- 0.000999
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -2.01 | 528 | 413 | 1.28 | 0.0000215 | 5029 |
| Missense (PolyPhen) | 200 | 170.33 | 1.1742 | 2165 | ||
| Synonymous | -0.236 | 164 | 160 | 1.02 | 0.00000907 | 1577 |
| Loss of Function | 0.662 | 35 | 39.5 | 0.886 | 0.00000188 | 496 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00088 | 0.00086 | rare |
| Latino/Admixed American | 0.00095 | 0.00093 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.0057 | 0.0057 | notable |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00074 | 0.00073 | rare |
| South Asian | 0.00042 | 0.00042 | rare |
| Other | 0.00065 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Sodium-independent transporter of chloride and iodide. {ECO:0000269|PubMed:10192399}.;
- Disease
- DISEASE: Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNB4 is associated with an enlarged vestibular aqueduct. {ECO:0000269|PubMed:10190331, ECO:0000269|PubMed:10700480, ECO:0000269|PubMed:11748854, ECO:0000269|PubMed:12676893, ECO:0000269|PubMed:14508505, ECO:0000269|PubMed:14679580, ECO:0000269|PubMed:19204907, ECO:0000269|PubMed:20108392, ECO:0000269|PubMed:20597900, ECO:0000269|PubMed:24051746, ECO:0000269|PubMed:28281779, ECO:0000269|PubMed:9500541}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.439
Intolerance Scores
- LoFtool
- 0.0893
- RVIS EVS
- 1.14
- RVIS percentile EVS
- 92.34
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.192
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |